229 related articles for article (PubMed ID: 26679802)
1. Immunoregulatory signal FoxP3, cytokine gene expression and IFN-γ cell responsiveness upon porcine reproductive and respiratory syndrome virus (PRRSV) natural infection.
Ferrarini G; Borghetti P; De Angelis E; Ferrari L; Canelli E; Catella A; Di Lecce R; Martelli P
Res Vet Sci; 2015 Dec; 103():96-102. PubMed ID: 26679802
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
3. Cytokine expression, glucocorticoid and growth hormone changes after porcine reproductive and respiratory syndrome virus (PRRSV-1) infection in vaccinated and unvaccinated naturally exposed pigs.
Borghetti P; Saleri R; Ferrari L; Morganti M; De Angelis E; Franceschi V; Bottarelli E; Martelli P
Comp Immunol Microbiol Infect Dis; 2011 Mar; 34(2):143-55. PubMed ID: 20655592
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
Charerntantanakul W; Pongjaroenkit S
Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
[TBL] [Abstract][Full Text] [Related]
6. Induction of inducible CD4+CD25+Foxp3+ regulatory T lymphocytes by porcine reproductive and respiratory syndrome virus (PRRSV).
Wongyanin P; Buranapraditkun S; Chokeshai-Usaha K; Thanawonguwech R; Suradhat S
Vet Immunol Immunopathol; 2010 Feb; 133(2-4):170-82. PubMed ID: 19709757
[TBL] [Abstract][Full Text] [Related]
7. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
[TBL] [Abstract][Full Text] [Related]
8. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
Zhang Z; Wang Y; Fan H; Lu C
Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
[TBL] [Abstract][Full Text] [Related]
9. Analysis of constitutive cytokine expression by pigs infected in-utero with porcine reproductive and respiratory syndrome virus.
Feng WH; Tompkins MB; Xu JS; Zhang HX; McCaw MB
Vet Immunol Immunopathol; 2003 Jul; 94(1-2):35-45. PubMed ID: 12842610
[TBL] [Abstract][Full Text] [Related]
10. The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.
Nilubol D; Platt KB; Halbur PG; Torremorell M; Harris DL
Vet Microbiol; 2004 Aug; 102(1-2):11-8. PubMed ID: 15288922
[TBL] [Abstract][Full Text] [Related]
11. Nasal delivery of chitosan/alginate nanoparticle encapsulated bee (Apis mellifera) venom promotes antibody production and viral clearance during porcine reproductive and respiratory syndrome virus infection by modulating T cell related responses.
Lee J; Kim YM; Kim JH; Cho CW; Jeon JW; Park JK; Lee SH; Jung BG; Lee BJ
Vet Immunol Immunopathol; 2018 Jun; 200():40-51. PubMed ID: 29776611
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs.
Kim T; Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
Clin Vaccine Immunol; 2015 Jun; 22(6):631-40. PubMed ID: 25855554
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
[TBL] [Abstract][Full Text] [Related]
14. Concurrent vaccination of pigs with type 1 and type 2 porcine reproductive and respiratory syndrome virus (PRRSV) protects against type 1 PRRSV but not against type 2 PRRSV on dually challenged pigs.
Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
Res Vet Sci; 2015 Dec; 103():193-200. PubMed ID: 26679817
[TBL] [Abstract][Full Text] [Related]
15. Immune response of porcine alveolar macrophages to a concurrent infection with porcine reproductive and respiratory syndrome virus and Haemophilus parasuis in vitro.
Kavanová L; Prodělalová J; Nedbalcová K; Matiašovic J; Volf J; Faldyna M; Salát J
Vet Microbiol; 2015 Oct; 180(1-2):28-35. PubMed ID: 26358898
[TBL] [Abstract][Full Text] [Related]
16. Development of a DNA-launched replicon as a vaccine for porcine reproductive and respiratory syndrome virus.
Pujhari S; Baig TT; Hansra S; Zakhartchouk AN
Virus Res; 2013 May; 173(2):321-6. PubMed ID: 23353778
[TBL] [Abstract][Full Text] [Related]
17. Immune response against porcine reproductive and respiratory syndrome virus during acute and chronic infection.
Molina RM; Cha SH; Chittick W; Lawson S; Murtaugh MP; Nelson EA; Christopher-Hennings J; Yoon KJ; Evans R; Rowland RR; Wu W-; Zimmerman JJ
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):283-92. PubMed ID: 18835044
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of immune responses to porcine reproductive and respiratory syndrome virus in pigs during early stage of infection under farm conditions.
Dwivedi V; Manickam C; Binjawadagi B; Linhares D; Murtaugh MP; Renukaradhya GJ
Virol J; 2012 Feb; 9():45. PubMed ID: 22340040
[TBL] [Abstract][Full Text] [Related]
19. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
20. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
